Overview

A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

Status:
SUSPENDED
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, and pharmacokinetics of ABBV-1088 in healthy adult Western, Han-Chinese and Japanese participants. This study will also assess drug-drug interaction between itraconazole and ABBV-1088 in healthy adult Western participants.
Phase:
PHASE1
Details
Lead Sponsor:
AbbVie
Treatments:
Itraconazole